Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers
Harshal Surendra Mandavdhare, Vishal Sharma, Kaushal K Prasad, Amit Kumar, Manish Rathi, Surinder S Rana
Intest Res. 2017;15(3):419-421.   Published online 2017 Jun 12     DOI: https://doi.org/10.5217/ir.2017.15.3.419
Citations to this article as recorded by Crossref logo
Systematic review: Clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers
Annalisa Schiepatti, Paolo Minerba, Michele Puricelli, Stiliano Maimaris, Giovanni Arpa, Federico Biagi, David S. Sanders
Alimentary Pharmacology & Therapeutics.2024; 59(4): 432.     CrossRef
Olmesartan induced enteropathy affecting the entire gastrointestinal tract: a case report
N Van Horebeek, R Croes, A Vonck, E Colpaert
Acta Gastro Enterologica Belgica.2023; 86(1): 95.     CrossRef
Olmesartan induced gastritis and enteropathy
Ankur Gupta, Priyanka Jain, Latika Gupta
Indian Journal of Gastroenterology.2023;[Epub]     CrossRef
A Case of Sprue-like Enteropathy Associated With Valsartan and Irbesartan
Seo Yeon Yoo, Jihun Kim, Kee Wook Jung
Journal of Neurogastroenterology and Motility.2022; 28(2): 327.     CrossRef
The histological spectrum of ARB‐induced gastritis
Tanner Storozuk, Ian Brown, Stephen Lagana, Maria Westerhoff, Namrata Setia, John Hart, Lindsay Alpert
Histopathology.2022; 81(5): 653.     CrossRef
Severe cases of sprue‐like enteropathy associated with angiotensin receptor blockers other than olmesartan
Peter Malfertheiner, Chiara Formigoni
GastroHep.2021; 3(2): 88.     CrossRef
Telmisartan-induced sprue-like enteropathy: a case report
Natalia Alzueta, Amaya Echeverría, Lorea Sanz, Carmen Fontela, Teresa Acín, Lidia Montenegro, Javier Garjón
European Journal of Hospital Pharmacy.2020; 27(1): 49.     CrossRef
Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture
Francesco Abbruzzi, Ilaria Loconte, Sonia Carparelli, Enzo Ierardi, Alfredo Di Leo, Mariabeatrice Principi
Current Drug Safety.2020; 15(1): 65.     CrossRef
Traitement par olmésartan et entéropathie : à propos de deux cas et revue de la littérature
A. Sadki, M. Le Besnerais, F. Héron, I. Marie
La Revue de Médecine Interne.2019; 40(2): 112.     CrossRef
A simple treatment for a potentially life-threatening cause of malabsorption
Mattia Bonzi, Elisa M. Fiorelli, Gaia Montanelli, Ludovico Furlan, Monica Solbiati
Internal and Emergency Medicine.2019; 14(6): 967.     CrossRef
Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review
Ayesha Kamal, Christopher Fain, Angela Park, Peiqi Wang, Eduardo Gonzalez-Velez, Daniel A Leffler, Susan M Hutfless
Gastroenterology Report.2019; 7(3): 162.     CrossRef
Association of sprue-like enteropathy and angiotensin receptor-1 antagonists
René R. Wenzel, Christian Datz
Wiener klinische Wochenschrift.2019; 131(19-20): 493.     CrossRef
Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy
Peter Malfertheiner, Claudio Ripellino, Nazarena Cataldo
Pharmacoepidemiology and Drug Safety.2018; 27(6): 581.     CrossRef